Results 221 to 230 of about 29,718 (289)

Humoral epitope dominance and immune imprinting by SARS‐CoV‐1 and SARS‐CoV‐2 vaccines

Immunology &Cell Biology, Volume 104, Issue 2, Page 150-167, February 2026.
We investigated Modified Vaccinia Ankara (MVA) vaccine candidates expressing the SARS‐CoV‐1 or SARS‐CoV‐2 Spike, as a primary or booster immunization, for their ability to induce antibodies targeting different epitopes on the SARS‐CoV‐2 RBD and broad cross‐reactive or cross‐neutralizing responses in C57BL/6 and antibody humanized (Ig‐humanized) mice ...
Deborah L Burnett, Ania Moxon, Anupriya Aggarwal, Katherine JL Jackson, Catherine Cotter, Anouschka Akerman, Amanda Russell, Rachel Kalman, David Langley, Jake Y Henry, Daniel Christ, Rowena A Bull, Robert Brink, Anthony D Kelleher, Hans‐Martin Jäck, Stuart Turville, Bernard Moss, Christopher C Goodnow   +17 more
wiley   +1 more source

Measles Antibodies Measured by Plaque Reduction Neutralization Test in Infants during the First Year of Life

, 2004
Sung Hee Oh, Hak Won Kim, Younghee Lim, Hahng Lee   +3 more
openalex   +1 more source

Receptor‐Dependent and ‐Independent Effects of Hemin on Platelet Plasma Membrane Disintegration

The FASEB Journal, Volume 40, Issue 2, 31 January 2026.
Microhemorrhages lead to the release of erythrocytes, which are then degraded and lysed. These hemolyses result in the liberation of free iron‐containing hemin. Hemin induces platelet activation and ferroptosis. Inhibition of GPVI/CLEC‐2 receptor‐mediated ITAM‐signaling inhibits hemin‐induced platelet activation (low hemin concentrations). Deferoxamine,
Zoi Laspa, Anne‐Katrin Rohlfing, Ravi Hochuli, Pamela Weronika Sowa, Tatsiana Castor, Meinrad Paul Gawaz   +5 more
wiley   +1 more source

Pseudovirus-Based Neutralization Assays as Customizable and Scalable Tools for Serological Surveillance and Immune Profiling. [PDF]

Pathogens
Denani CB, Setatino BP, Pereira D, Horbach IS, Azevedo AS, Coutinho G, Ferroco CL, Xavier J, Leite R, Santos E, Maia ML, Schwarcz WD, Sousa IP.   +12 more
europepmc   +1 more source

Application of Orthoflavivirus Pseudovirus Technology in Antiviral Research. [PDF]

Int J Mol Sci
Zhang Y, Zhao Y, Wang C, Zhou Y, Yuan H, Li X, Wang Y, Pan X.   +7 more
europepmc   +1 more source

Pro-inflammatory cytokine profiles and neutralizing antibodies in JYNNEOS-vaccinated and mpox-diagnosed individuals. [PDF]

NPJ Vaccines
Maciel MSC, de Souza Andrade A, Neri de Oliveira AL, Arias NEC, de Carvalho SH, Xavier MAP, Kroon EG, Campos MA.   +7 more
europepmc   +1 more source

Comment on: A single dose recombinant AAV based CHIKV vaccine elicits robust and durable protective antibody responses in mice. [PDF]

PLoS Negl Trop Dis
Xu S, Li K, Merits A, Dai Z, Luo J, Zhong X, Zhang O, Yang J, Yang X.   +8 more
europepmc   +1 more source

Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies

, 2012
Marisol Simões, Luiz Antônio Bastos Camacho, Anna M. Y. Yamamura, Emily Hime Miranda, Ana Cajaraville, Marcos da Silva Freire   +5 more
openalex   +2 more sources

Sero-neutralizing antibody against orthopoxviruses in populations of Wuhan, China. [PDF]

Mol Biomed
Gao Z, Liu T, Zhao Z, Wang B, Hou L.
europepmc   +1 more source

Validation of Chimeric Viruses in Plaque Reduction Neutralization Test in Arboviral Disease Diagnostics

, 2017
Jasmine Boykin
openalex   +1 more source